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Objectives. The aim of this study was to determine the relative
risks of pediatric diagnostic, interventional and electrophysiologic
catheterizations.
Background. The role of the pediatric catheterization labora-
tory has evolved in the last decade as a therapeutic modality,
although remaining an important tool for anatomic and hemody-
namic diagnosis.
Methods. A study of 4,952 consecutive pediatric catheterization
procedures was undertaken.
Results. Patient ages ranged from 1 day to 20 years (median 2.9
years). One or more complications occurred in 436 studies (8.8%)
and were classified as major in 102 and minor in 458, with
vascular complications (n 5 189; 3.8% of procedures) the most
common adverse event. Arrhythmic complications (n 5 24) were
the most common major complication. Death occurred in seven
cases (0.14%) as a direct complication of the procedure and was
more common in infants (n 5 5). Independent risk factors for
complications included a young patient age and undergoing an
interventional procedure.
Conclusions. Complications continue to be associated with
pediatric cardiac catheterization. Efforts should be directed to
improving equipment for flexibility and size, and finding alterna-
tive methods for vascular access. Patient age and interventional
studies are risk factors for morbidity and mortality.
(J Am Coll Cardiol 1998;32:1433–40)
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Over the last decade, the pediatric catheterization laboratory,
while continuing to play a significant role in anatomic and
hemodynamic diagnosis, has evolved a therapeutic function
(1,2). All such procedures, both diagnostic and interventional,
are associated with some risk. To this end, a number of studies
have addressed the risk of each form of invasive study (3–10),
but were retrospective or reviewed relatively small patient
numbers. To achieve an understanding of the relative risks of
all such procedures, a prospective 7-year study was undertaken
to determine the incidence of adverse events and predisposing
factors associated with pediatric interventional and diagnostic
cardiac catheterization.
Methods
Study patients. During the period January 1, 1987, through
December 31, 1993, all patients undergoing cardiac catheter-
ization at The Hospital for Sick Children, Toronto, Ontario,
Canada, had documentation of any adverse event on a case
report form. During that period, 4,952 cardiac catheterizations
were performed at a median age of 2.9 years (range, 1 day to
20 years), with 55% being males and 45% being females.
Data collection and study design. Procedures were classi-
fied as diagnostic (DGN), interventional (INTV) or electro-
physiologic (EP). The INTV studies included all procedures
where an attempted catheter therapy (e.g., septostomy, angio-
plasty, device implantation, embolization) occurred. The EP
studies were defined as those procedures performed primarily
to evaluate an arrhythmic problem. All other studies address-
ing anatomic or hemodynamic issues (including endomyocar-
dial biopsy) were classified as DGN. A few patients were
classified in two categories if each component was required for
patient management. Records were maintained for complica-
tions related to the procedure. Complications were divided
into major and minor. Major complications included all events
leading to one of the following: a) death; b) life-threatening
hemodynamic decompensation requiring immediate therapy
(e.g., cardiac arrest, severe hypotension); c) the need for
surgical intervention (e.g., removal of an embolized implanted
device); or d) a significant unanticipated permanent anatomic
or functional lesion resulting from the catheterization (e.g.,
cerebral infarct, permanent arterial thrombosis, vessel tear or
aneurysm). Minor complications were defined as unanticipated
events that were transient and resolved with specific treatment
(e.g., transient arterial thrombosis or tolerated transient ar-
rhythmic episode). Furthermore, in addition to the above
event characterizations, episodes were categorized as vascular
related (e.g., vessel thrombosis, aneurysms, etc.), bleeding,
arrhythmias, deaths, events related to INTV procedures (e.g.,
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device embolization), catheter manipulations (e.g., cardiac
perforation, balloon rupture) and a miscellaneous grouping. If
a complication was recorded, the patient hospital and cardiac
records were reviewed to determine the treatment and the
effect of the event on the patient’s course.
Arterial complications. To define predictors of arterial
complications a nested case-control study was undertaken.
From those patients noted to have arterial complications, 50
patients were randomly selected and matched by age and date
of catheterization to a control patient who had no arterial
complication. Detailed information related to possible predic-
tor variables such as patient weight, height and body surface
area, hemoglobin concentration, systemic arterial oxygen sat-
uration, size of the largest arterial catheter or sheath, duration
of the procedure, fluoroscopy time, bolus dose of heparin
sulfate administered and the amount of radiographic dye used
were compared between the two groups.
Catheterization technique. Diagnostic and therapeutic
procedures were performed according to previously described
techniques (2,7,11,12). Patients for elective studies were gen-
erally admitted to the hospital the day of the procedure.
General anesthesia was used for all INTV-EP procedures (13).
Heparin sulfate (150 IU/kg) was administered intravenously
after any peripheral arterial access and repeated after 2 h
(75 IU/kg). Cineangiography was performed using a nonionic
contrast agent (Isovue 300, Squibb Diagnostics, Montreal,
Canada) at a dose of 0.5 to 2.0 ml/kg, average total dose per
case, 4 ml/kg.
Statistical evaluation. Descriptive statistics for the total
population and all complications were obtained and included
frequencies, medians with ranges and means with standard
deviations. Independent risk factors for any complication and
for any major complication were sought using stepwise multi-
ple logistic regression analysis. Factors that were tested in-
cluded patient age, weight and gender, and the year and type
of catheterization procedure. The stepwise logistic regression
was performed using SAS Institute Software (Version 6.12,
Cary, North Carolina). A p value of ,0.10 was used for
selection for entry into the model, with a p value of ,0.05
necessary for retention. Categories of categorical variables
were entered as dummy variables into the model, with one
category excluded as a reference variable. When a categorical
variable was entered into the model, all categories were
required to be present in the model for retention. Only a
limited number of candidate variables were selected for testing
in the model, that is, those with bivariate p values of ,0.25.
Significant continuously measured variables were categorized
to determine the nature of the linear relationship with the
defined outcome. Hosmer–Lemeshow goodness-of-fit testing
was used to test the final models. To determine risk factors for
arterial complications, cases and controls (see above) were
compared using paired t tests and signed rank tests. The level
of statistical significance was set at p , 0.05.
Results
General information. Among the 4,952 catheterizations,
1,081 procedures (22%) were performed with discharge the
day of the study. In 1987, 12% were outpatient procedures; in
1993, 34% were performed in this format. In 964 cases (19% of
the total catheterizations) patients were ,6 months of age.
There were 3,149 DGN, 1,371 INTV (45 had 2 INTV proce-
dures), 383 EP and 41 INTV-EP catheterizations. The INTV
studies represented 29% of the total number of catheteriza-
tions throughout the study period, increasing in number from
14% in 1987 to 43% in 1993, while EP studies represented 9%
of the total number of cardiac catheterizations. One or more
complications occurred in 436 (8.8%) procedures at a median
patient age of 1.1 years, with a maximum number of compli-
cated catheterizations in 1993 (n 5 98, 13%) and a minimum
in 1989 (n 5 38, 5.4%). Adverse events were more likely to
occur in younger patients. In 964 catheterizations on infants
,6 months, 1 or more complications occurred in 135 cases, an
incidence of 14%, the highest of all age groups, reported in 70
of 632 DGN studies and 65 of 322 INTV studies. Complica-
tions were significantly less likely in patients .10 years of age,
and occurred in only 45 cases (Mantel–Hantzel chi-square, p ,
0.01). One hundred and two major complications occurred
during 74 procedures at a median patient age of 0.6 years
(range, 1 day to 17 years), and 458 minor complications in 385
procedures at a median age of 1.3 years (range, 1 day to 18
years). The most common major complication was an arrhyth-
mia (n 5 24), while vascular complications had the highest
incidence among minor adverse events (n 5 189).
Complication by category (see Table 1). Deaths. Seven
patient deaths were directly related to the catheterization
(Table 2). All were critically ill, requiring ventilatory support
prior to their study. Of 465 procedures involving neonates
(,30 days of age), 4 catheterization-related deaths occurred
(0.9%), significantly (p , 0.01) more frequent than in older
patients. No deaths were reported in patients .5 years of age.
Arrhythmias. Rhythm disturbances occurred in 128 cases
(2.6% of all cases) and included 24 major events. The most
common arrhythmic event was atrioventricular block. Com-
plete atrioventricular block occurred in 20 cases; 5 patients
required pacing during the procedure, with recovery of sinus
rhythm prior to discharge in all. First or second degree
atrioventricular block was well tolerated at all ages and uni-
formly resolved. Supraventricular tachycardia complicated
catheterization in 25 cases, but never progressed to a major
adverse event, although in 9 cases cardioversion was required.
When complete bundle branch block occurred it generally
resolved shortly after the procedure, persisting in only one
Abbreviations and Acronyms
DGN 5 diagnostic
EP 5 electrophysiologic sudy
INTV 5 interventional
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patient. ST-segment elevation was always a transient event,
four episodes being related to entry into the left atrium
through a long sheath during an INTV-EP study. Ventricular
tachycardia or fibrillation occurred in 8 cases each, 4 patients
being ,6 months of age. Cardiopulmonary resuscitation was
required in 12 patients, 4 of whom died in the laboratory.
Table 1. Distribution of Major and Minor Complications
Major Minor Totals*
Deaths 7 7 (1.2%)
Arrhythmias 24 104 128 (22.9%)
Bradycardia 7 17
Supraventricular tachycardia 25
Ventricular tachycardia/fibrillation 8
Complete atrioventricular block 9 11
1°, 2° atrioventricular block 29
Bundle branch block 9
ST-segment elevation 12
Junctional rhythm 1
Cardiac arrest 12 12 (2.1%)
Vascular 18 171 189 (33.7%)
Arterial thrombosis 11 154
Decreased/absent pulse with resolution (heparin) 96
Decreased/absent pulse with resolution (thrombolytics) 57
Decreased/absent pulse requiring surgery 2
Decreased/absent pulse without resolution 9
Decreased/absent pulse, death before resolution 1
Venous thrombosis 9
Perforation
Arterial 4 3
Venous 3
Others (tears, avulsions) 3 2
Bleeding 5 37 42 (7.5%)
At catheterization site (hematoma) 25
At other sites 5 12
Relating to catheter manipulation 10 34 44 (7.9%)
Myocardial/vessel stain 19
Cardiac perforation 5 8
Cardiac tamponade 5
Air embolus 4
Catheter-wire complication (break/fixation/knot) 3
Relating to interventional procedures 11 40 51 (9.1%)
Balloon rupture 12
Device embolization 4 15
Other 7 13
Miscellaneous 15 72 87 (15.5%)
Total 102 458
* 5 % of total complications.
Table 2. Mortality
Age Cardiac Lesion Notes Procedure Event Leading to Death Location
1 1 day PAT, intact ventricular septum On PGE1 Diagnostic Perforation of the left atrium Cath lab
2 3 days PAT, ventricular septal defect On PGE1 Pulmonary valve dilation Ductal thrombosis OR
3 14 days DORV, TGA Balloon atrial septostomy Cardiac perforation Cath lab
4 4 yr AVSD, right ventricular hypoplasia p/o day 4 Fontan Stent in branch pulmonary artery Cardiac tamponade ICU
5 5 yr DILV, TGA p/o day 1 Fontan Atrial defect dilation Desaturation and bradycardia Cath lab
6 4 month PAT, ventricular septal defect Cyanotic Diagnostic Desaturation and bradycardia Cath lab
7 3 day AVS, coarc Diagnostic Bleeding from perforation of
paraductal area
OR
AVSD 5 atrioventricular septal defect; DILV 5 double inlet left ventricle; DORV 5 double outlet right ventricular; ICU 5 intensive care unit; OR 5 operating
room; PAT 5 pulmonary atresia; PGE1 5 prostaglandin E1; TGA 5 transposition of the great arteries.
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Vascular. An arterial thrombosis, with either a decreased
or absent pulse, was present at the end of 165 cases, with
restoration of patency in 153 cases. An INTV procedure was
responsible for arterial thrombosis in 71 (43%) cases, with
aortic valve dilation or coarctation/recoarctation angioplasty
being the most common procedures performed (14,15). In the
majority of the cases a continuous infusion of heparin sulfate,
adjusted to a partial thromboplastin time of 80 to 120 s, was
sufficient to regain vessel patency within 24 to 48 h (16). In 57
instances, a thrombolytic agent (streptokinase or tissue throm-
boplastin activator) was required for restoration of the pulse,
had it not occurred with heparin sulfate (16). Surgical throm-
bectomy was required in two cases, with improved perfusion in
both, although the limb pulse remained weak in one. Arterial
thrombosis was permanent in 9 patients, occurring at a median
age of 105 days of age (range: 70 days to 1.6 years). One patient
with an absent pulse died before resolution could be ascer-
tained.
Bleeding. This was a problem in only five cases. The most
significant, and dramatic, occurred in a 6-month-old who had
undergone aortic valvotomy. Retroperitoneal bleeding from a
tear in the iliac artery resulted in acute and severe hypotension
prompting surgical repair. Two additional patients required
blood transfusions for blood loss during their procedures.
Local bleeding (hematoma) was noted at the groin in 25 cases
and in the mediastinum in 2 cases (1 each from the left
subclavian artery which had been cannulated, and the superior
vena cava, after stent implantation). None of these patients
required blood transfusion.
Complications related to catheter manipulations. There were
10 major complications, including 5 cardiac perforations with
cardiac tamponade, all occurring during INTV procedures. A
pericardiocentesis (n 5 4) or surgical repair was performed.
Among other minor complications, myocardial stains during
angiography were the most frequent (n 5 19) but never
evolved to a major adverse event.
Complications related to INTV procedures. During the pe-
riod of study there were 1,457 interventional procedures
(INTV and INTV-EP) performed during 1,412 catheteriza-
tions (Table 3). Complications were significantly more com-
mon in these studies, occurring in 13% of patients. The
incidence of complications (of any kind) during INTV studies
was not constant during the period of study, however, being
23% of INTV cases in 1987, declining to 10% in 1990, but
increasing to 18% in 1993. In 3.2% of the interventional
procedures (n 5 46) major complications occurred, while in
10% (n 5 145) there were minor complications. However, only
11 major and 40 minor complications were directly related to
the intervention itself (Table 1). Balloon aortic dilation had the
highest incidence of complications (42%), followed by dilation
of Fallot’s tetralogy (40%) and recoarctation angioplasty
(30%). Low-risk procedures included occlusion of the persis-
tent arterial duct (5%) and pericardiocentesis (3%). Three
patients had embolization of an occluder device, requiring
surgical removal. One patient had significant hemolysis also
requiring surgical removal 4 days after implant (17). Aortopul-
monary shunt thrombosis occurred in one patient, requiring
thrombolysis, and three patients undergoing aortic balloon
dilation developed severe aortic insufficiency and were taken
electively for surgical repair, with only mild insufficiency post-
operatively. Embolization or malpositioning of an implantable
device occurred as a minor adverse event, with devices re-
trieved in the laboratory (n 5 8) or left in place without
hemodynamic consequences (n 5 7). The embolized devices
included coils in six instances, six ductal umbrella occluders,
one atrial defect occluder and two endovascular stents. Devices
left in place included one ductal umbrella, one stent and five
coils.
Miscellaneous events. Infection as a minor adverse event
was localized to the catheter entry site in two patients and
systemically in two others, all requiring intravenous antibiotics.
A drug reaction occurred in 13 cases, but in only 1 patient was
Table 3. Interventional Cardiac Procedures and Related Complications*
Procedure n Major Minor Total
Aortic valve dilation 91 14 24 38
Atrial septal defect closure 80 3 9 12
Atrial septal defect dilation 12 1 1 2
Balloon atrial septostomy 154 5 22 27
Coarctation angioplasty 40 0 7 7
Ductus arteriosus occlusion 361 4 13 17
Mitral valve dilation 5 1 0 1
Pericardiocentesis 77 1 1 2
Pulmonary artery angioplasty 129 2 8 10
Pulmonary valve dilation 162 1 7 8
Radiofrequency ablation 41 1 4 5
Recoarctation angioplasty 63 6 13 19
Stent in pulmonary artery 162 6 16 22
Stent in pulmonary vein 5 0 0 0
Tetralogy of Fallot/pulmonary atresia valve dilation 10 1 3 4
Ventricular septal defect closure 4 0 1 1
Miscellaneous embolization 61 0 16 16
*Performed in 1,412 cardiac catheterizations.
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it a major complication when the patient developed hypoten-
sion after administration of protamine sulfate. Respiratory
problems, including respiratory distress or hypoventilation
(n 5 10) or hypercyanotic spells (n 5 8), evolved into a major
complication in only one case, where the patient developed
pulmonary edema requiring treatment. No major complica-
tions were related to general anesthesia, although mild self-
limiting stridor shortly after a procedure occurred in three
patients. Transient hypothermia occurred without evidence of
infection in 8 patients (median age 8 months, range, 2 days to
5 years). Cerebral infarction defined by computed tomographic
scanning occurred in 3 patients of 12, 14 and 26 months of age
and in 2 patients after an INTV procedure (recoarctation
dilation in 1 and an atrial septal defect closure in the other).
These events were thought to be related to transient cerebral
hypoperfusion in one patient (18) or an inadvertent air embo-
lism in two. Seizures complicated two procedures, following a
supraventricular tachycardia in one patient and a drug reaction
in another. One major complication occurred in a patient
undergoing emergency stent implantation into the right pul-
monary artery within days after attempted surgical repair. The
child became hypotensive after the implant, had the chest
opened and clots around the heart removed. No discrete
bleeding sites were observed and the child was returned to the
intensive care unit, ultimately recovering.
Risk Factors
The only independent risk factors for any complication
included the year of the catheterization, the type of procedure
and the age of the patient. The age of the patient and the year
of catheterization were categorized and reentered into a
multiple logistic regression model (Table 4). After controlling
for age and type of procedure, the highest risk occurred in 1993
with a nadir in 1989 and 1990. Relative to 5-to-9 year olds, the
independent risk of complications was greatest up to 2 years of
age. Relative to diagnostic procedures, interventional catheter-
izations were independently associated with a greater risk of
complication.
Independent risk factors associated with the presence of a
major complication included patient weight, type of procedure
and if the patient was a hospital inpatient at the time of the
procedure (Table 5). After categorizing patient weight, the risk
of a major complication was significantly greater, relative to
the 20 kg to ,40 kg patient group, for patients who were
,10 kg at the time of the procedure. Risk was independently
reduced if the patient was an outpatient at the time of the
procedure and for INTV catheterizations.
Risk factors for arterial complications were sought in the
matched case-control study. There were no significant differ-
ences between the ages and dates of procedures for the 50
cases and the 50 matched controls in assessment of risk factors
for arterial complications. Three of the cases did not have
arterial catheters or sheaths placed at catheterization, but the
artery was entered briefly during attempts to enter the vein.
The catheterization was for diagnostic purposes for 56% of
cases and 68% of controls (p 5 ns), and 56% of patients in
both groups had had a previous catheterization. There were no
differences between matched cases and controls regarding
height, weight, body surface area, systemic arterial oxygen
saturation, duration of procedure, fluoroscopy time or the
amount of radiographic dye used per kilogram of patient
weight. There was a trend (p 5 0.06) toward decreased
hemoglobin concentrations in the cases. While there was no
significant difference regarding the amount of heparin bolus
given per kilogram, cases had lower doses when adjusted for
the duration of the procedure. Cases also had larger arterial
sheaths or catheters when French size was adjusted for the
body surface area of the patient.
Discussion
Throughout the nearly 50 years since the landmark works
reporting cardiac catheterization in children (19,20), technical
improvements have allowed the performance of invasive pro-
Table 4. Independent Risk Factors for Any Complication
Variable
Adjusted Odds Ratio*
(95% Confidence Level) p Value
Type of procedure
Diagnostic 1.00
Electrophysiologic 1.17 (0.76, 1.79) 0.48
Interventional 1.92 (1.56, 2.36) 0.0001
Age at procedure
,1 month 2.47 (1.66, 3.68) 0.0001
1 to ,6 months 2.86 (1.94, 4.23) 0.0001
6 month to ,2 yrs 2.35 (1.66, 3.33) 0.0001
2 yrs to ,5 yrs 1.18 (0.81, 1.72) 0.37
5 yrs to ,10 yrs 1.00
$10 yrs 0.85 (0.56, 1.29) 0.44
*From multiple logistic regression analysis, Hosmer–Lemeshow goodness of
fit statistic 3.26 with 8 d.f.; p 5 0.92.
Table 5. Independent Risk Factors for Major Complications
Variable
Adjusted Odds Ratio*
(95% Confidence Level) p Value
Type of patient
Inpatient 1.00
Outpatient 0.40 (0.16, 1.02) 0.055
Age at procedure
,1 month 3.63 (1.47, 8.97) 0.0053
1 to ,6 month 4.69 (1.90, 11.55) 0.0008
6 month to ,2 yrs 1.96 (0.79, 4.88) 0.15
2 yrs to ,5 yrs 1.27 (0.49, 3.30) 0.63
5 yrs to ,10 yrs 1.00
$10 yrs 0.79 (0.26, 2.37) 0.67
Type of procedure
Diagnostic 1.00
Electrophysiologic 1.65 (0.47, 5.77) 0.43
Interventional 2.38 (1.36, 4.16) 0.003
*From multiple logistic regression analysis, Hosmer–Lemeshow goodness of
fit statistic 8.12 with 8 d.f. (degrees of freedom); p 5 0.42.
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cedures reliably and safely, even in the youngest and smallest
of patients (2,12). Yet adverse events during such procedures
have not been completely eliminated. This is particularly true
with the expansion of the cardiac catheterization from a
primary anatomic–hemodynamic investigation to include ther-
apeutic interventions (1,3,5,6,11,21–23). In addressing these
complications, few reports detail the full spectrum related to
cardiac catheterization procedures in childhood (4), either
exclusively addressing interventional studies (3,5), reviewing
only relatively small numbers (4) or including an adult popu-
lation (3). This contemporary prospective study addresses all
complications occurring during cardiac catheterization studies
performed in a large tertiary care pediatric teaching cardiac
unit by multiple operators. Thus, this review summarizes risk
as it applies not only to the special skills of the interventional
cardiologist, but those experienced by staff physicians and
trainees performing general diagnostic studies. From a popu-
lation of 4,952 patients, 560 complications were identified in
436 cases representing 102 major and 458 minor events. This
incidence is similar to earlier reports (4) but less than that
noted in older reviews (6,7) or studies addressing exclusively
interventional catheterizations (3,5).
Although death occurred in 0.14% of patients, the Coop-
erative Study on Cardiac Catheterization (8) conducted be-
tween 1963 and 1965 found a mortality of 0.44% from 12,364
studies performed from the newborn period through adult-
hood, the highest mortality (6.0%) in the first 2 months of life
and lowest (0.14%) over 2 years of age. A similar study
conducted on a pediatric population (1,859 patients, age range:
1 day to 15 years) between 1964 and 1970 found an overall
mortality of 1.5% (7), and between 1965 and 1967 from the
University of California, San Francisco (6) a reported mortality
of 0.26% was observed, or 3.1% if all deaths within 24 h were
considered. This same group recently reviewed their more
current experience and found death complicating 0.19% of
1,037 cases performed between 1986 and 1988, or a mortality
rate of 0.39% if all deaths within 24 h were included (4). All
reviews note that mortality is influenced by age, being signifi-
cantly higher in patients ,1 year and particularly high in
newborns, reflected by our experience and that from the New
England Regional Infant Cardiac Program where a mortality
of 3.8% (9) was noted. Despite these reports, a true mortality
rate for pediatric catheterization is difficult to determine from
the literature due to the various criteria used for collecting
population data. Although most authors included patients
dying within 24 h (4,6,7,10), some comment only upon those
deaths directly related to the procedure (4,6), or include only
diagnostic cases (6,7,10), interventional studies (4) or exclu-
sively therapeutic catheterizations (3,5). Additionally, while
some reports consider pediatric populations (4,5–7), others
include adults (3,8,24) or report only infants (9) or neonates
(10,25). Nevertheless, some inferences can be drawn from our
data and that of the literature. First, there is a decreasing risk
of mortality over the last decade, from 1.5 to 3.0% in earlier
reviews (6,7) to 0.14% in our experience. Indeed, a study from
this institution 20 years ago (26) noted a mortality rate in
newborns (within 24 h of the procedure) of 6.7% and an
overall incidence of death of 0.96%. This reduction in mortal-
ity relates to fewer procedures being required in infants and
newborns where anatomic information to guide management
can be obtained through alternative, noninvasive means (27–
29) or supplements noninvasive information, to improvement
in care for the critically ill child, improvement in catheters and
other support equipment (such as effective temperature con-
trol) and to the introduction of prostaglandin E1. Complica-
tions related to catheter manipulation were the most common
causes of death (57%) in our series, underscoring the need for
diligent technique in small patients and correction of any
abnormal metabolic parameter in the critically ill infant.
The overall incidence of arterial complications was 3.7%,
and 7.3% in those ,1 year of age, infrequently evolving into a
major complication, although in 1 child a 2-cm leg length
discrepancy developed (30–33). Avoiding arterial entry with
the use of alternative techniques to enter the left heart (34) can
avoid this complication. To this end, we have approached such
arterial compromise with an aggressive management strategy
after the procedure (16). Nevertheless, the true incidence of
arterial compromise is unknown, underscored by the recent
observations of Kocis et al. (34), who used Doppler ultrasonog-
raphy to examine arterial pulse flow after arterial cannulation.
These authors found a higher incidence of flow compromise
(32%) than that clinically suspected. There is unfortunately
little information to help predict how and when a reduced
pulse may result in delay in limb growth, and studies to define
this incidence and risk are badly needed. The INTV studies
were an independent risk factor for arterial complications, but
progress in reducing balloon and sheath sizes can, and to some
degree has, reduced the incidence of arterial injury (14,15).
Age was an additional independent risk factor, with 60% of
such complications in our population occurring in infancy.
Arrhythmias were the next most common complication,
with an incidence of 2.6% of the total studies, and the most
common cause of a major complication. This incidence is less
than that reported by other authors (4,6), although the dis-
crepancy may in part be related to different criteria for
inclusion (6,7). Among the 16 patients with either bradycardia
or complete heart block as a major complication, 8 were ,3
months of age. To prevent serious arrhythmias, judicious
catheter manipulation and correction of any metabolic abnor-
mality is critical, but being prepared for such events is vital.
The INTV procedures were more often associated with
cardiac perforations, related in some degree to the complex
nature of the procedures, small age and size of the patients and
large, stiff catheters. However, atrial wall perforation during
attempted transseptal puncture was well tolerated without the
need for further intervention after withdrawal if recognized
before the long sheath-dilator was advanced (35).
Complications related to INTV procedures have been
previously reported in the literature (1,3,17,23). Embolization
of implantable intravascular devices occurred in 19 procedures,
with a major complication occurring twice for ductal occlusion
in the years 1987 to 1988 and once for atrial septal defect
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occlusion in 1990; all occurred during the first applications of
these devices (36). However, implanting a double umbrella
device into the patent ductus arteriosus in infancy carries a
high risk for flow compromise to the left pulmonary artery
when the child is ,10 kg (17). The majority of these events,
however, have been defined months to years after implantation
(37). Only those few (n 5 2) in whom flow compromise was
manifest during the procedure were included in the study. The
so-called learning curve of a newly introduced INTV proce-
dure similarly impacts the complication rates. However, as
more INTV cardiologists are trained, it is anticipated that the
introduction of any new technique will be rapidly brought into
common application (38).
INTV-EP procedures. Complications after aortic valve di-
lation were the most frequent of any INTV procedures (42%),
a similar incidence as reported in the literature (1,3,5). Arterial
complications occurred in 29 cases, and appears related to
patient age (1,3,5), occurring in 18 of 19 infants in whom a
complication occurred. Severe aortic insufficiency occurred in
three patients, requiring surgical repair of the aortic valve.
Recoarctation angioplasty similarly had a high incidence of
complications (32% of procedures, primarily arterial). This is
less than that reported by Booth et al. (5) (53%), although
these authors did not differentiate dilation of native from
recurrent obstructions. Our incidence, however, was greater
than that reported by Fellows et al. (3) (4%), in part due to our
younger patient age (median age 12.5 months vs. 3.7 years). As
for aortic valve dilation, the insertion of a large catheter into
the artery was the substrate for an arterial complication,
common at all ages (33.7% of all complications) and greatest
in infants (41% of infant complications).
Electrophysiologic procedures. These had the lowest rate
of morbidity. Major complications occurred in only 0.7%, less
than those occurring during INTV (2.0%) procedures and similar
to the incidence observed during DGN procedures (0.8%).
Conclusions. Although significant improvements have oc-
curred in the diagnosis and management of the critically ill
patient with congenital heart disease, complications of cardiac
catheterizations cannot be avoided, although such events occur
less frequently than in the last decade. The morbidity associ-
ated with INTV catheterizations is significantly higher than
other types of procedures, although with an increasing propor-
tion of such catheterizations, an increasing incidence may be
expected. Efforts to further reduce mortality and morbidity can
be accomplished by improving equipment, catheter flexibility
and reduced procedure times. Prospective studies for defining
risk and impact on patient outcomes should be encouraged.
We thank Alice Newman for time and help given in statistical evaluation.
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